Indapta Therapeutics and Archon Biosciences Ranked in Puget Sound Business Journal’s Top 25 Startups to Watch

Indapta was founded in 2017 and raised a $22.5M round in December 2024. The company focuses on what are called “natural killer cells” and their ability to fight cancer and autoimmune diseases. 

Archon Biosciences launched from stealth in October 2024 with $20M in seed funding. Archon is developing medicines made up of antibodies and AI-made proteins that don’t exist in nature.